Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Total Assets : ¥4,548.2 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Total Assets?

Hebei Changshan Biochemical Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 was ¥4,548.2 Mil.

During the past 12 months, Hebei Changshan Biochemical Pharmaceutical Co's average Total Assets Growth Rate was -1.90% per year. During the past 3 years, the average Total Assets Growth Rate was -2.70% per year. During the past 5 years, the average Total Assets Growth Rate was 4.40% per year. During the past 10 years, the average Total Assets Growth Rate was 10.50% per year.

During the past 13 years, Hebei Changshan Biochemical Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 59.90%. The lowest was -2.70%. And the median was 16.90%.

Total Assets is connected with ROA %. Hebei Changshan Biochemical Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 was 0.33%. Total Assets is also linked to Revenue through Asset Turnover. Hebei Changshan Biochemical Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.06.

Hebei Changshan Biochemical Pharmaceutical Co Total Assets Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co Total Assets Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

4,572.56

5,189.85

6,035.80

4,596.45

4,522.76

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															4,670.17	4,775.11	4,686.23	4,522.76	4,548.18

Hebei Changshan Biochemical Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hebei Changshan Biochemical Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	1535.739	+	2987.021
	=	4,522.8

Hebei Changshan Biochemical Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	1540.222	+	3007.953
	=	4,548.2

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Total Assets Explanation

Total Assets is connected with ROA %.

Hebei Changshan Biochemical Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	15.132	/	( (4522.761	+	4548.175)	/ 2 )
	=	15.132	/	4535.468
	=	0.33 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hebei Changshan Biochemical Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	258.703	/	( (4522.761	+	4548.175)	/ 2 )
=	258.703	/	4535.468
=	0.06

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hebei Changshan Biochemical Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines